Clinical trials: Sexual Function
Vulvar Atrophy, Vulvovaginal Signs and Symptoms
Retrospective Cohort Study of Symptoms and Quality of Life in Women With Genitourinary Syndrome of Menopause.
The goal of this clinical trial is to retrospectively identify the most prevalent symptoms of genitourinary syndrome of menopause (GSM) among postmenopausal women and to evaluate their impact on quality of life.
- Conditions
- Vulvar Atrophy, Vulvovaginal Signs and Symptoms, Genitourinary Syndrome of Menopause (GSM), Quality of Life
- Trial name
- NCT07737782
- Where
- Spain
- Volunteers
- 100 people
- Sponsor
- Mucosa Innovations, S.L.
Vulvar Atrophy, Vulvovaginal Signs and Symptoms
Changes in the Impact of Genitourinary Syndrome of Menopause With a Novel Nonhormonal Vulvovaginal Gel Assessed by PROMs.
The goal of this clinical trial is to improve the management of Genitourinary syndrome of menopause (GSM) to preliminary assess safety and effectivity of a novel hormone-free mucosa composition (XCMIM20m) applied topically to the…
- Conditions
- Vulvar Atrophy, Vulvovaginal Signs and Symptoms, Genitourinary Syndrome of Menopause, Quality of Life
- Trial name
- STOPGSMP (NCT06962345)
- Testing
- Hormone-free vulvovaginal gel with the tested composition XCMIM20m
- Where
- Spain
- Volunteers
- 80 people
- Sponsor
- Mucosa Innovations, S.L.
Sexual Satisfaction, Sexual Function
Radicle Spark for Men 24: A Study of Health and Wellness Products on Sexual Health and Related Health Outcomes
A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on sexual health and related health outcomes
- Trial name
- NCT06590337
- Testing
- Spark Active Study Product 1.1 Usage, Spark Active Study Product 2.1 Usage
- Where
- United States
- Volunteers
- 1,202 people, healthy volunteers welcome
- Sponsor
- Radicle Science
Sexual Satisfaction, Sexual Function
Radicle Spark for Women™ 24: Assessing the Impact of Health and Wellness Products on Sexual Health and Related Health Outcomes
A randomized, double-blind, placebo-controlled, direct-to-consumer study assessing the impact of health and wellness products on sexual health and related health outcomes.
- Trial name
- NCT06891547
- Testing
- Spark Active Study Product 5.1 Usage
- Where
- United States
- Volunteers
- 600 people, healthy volunteers welcome
- Sponsor
- Radicle Science
Sexual Function, Cognitive Functions
A Clinical Trial to Evaluate the Efficacy of a Men's Supplement in Supporting Testosterone, Improving Cognitive Function, Mood, and Sexual Function
This randomized, triple-blind, placebo-controlled, hybrid trial aims to evaluate the efficacy of a men's supplement designed to increase testosterone levels and improve energy, cognition, and sexual function.
- Conditions
- Sexual Function, Cognitive Functions, Testosterone
- Trial name
- NCT06596928
- Testing
- Essential Elements T-Hero Platinum
- Where
- United States
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- Scale Media Inc
Vaginal Laxity Following Childbirth, Sexual Function Following Childbirth
VIveve Treatment of the Vaginal Introitus to EValuate Effectiveness
Outside United States (OUS) Post-Market Parallel Group Exploratory Study Design The objective of this study is to determine the safety and effectiveness of the Viveve System to treat the vaginal introitus in women following…
- Trial name
- VIVEVE I (NCT02261974)
- Testing
- Active Treatment Viveve
- Where
- 9 sites in Canada, Italy and 2 more
- Volunteers
- 186 people
- Sponsor
- Viveve Inc.
Sexual Function and Fertility Disorders NEC-Erectile Dysfunction
Efficacy and Tolerability Study of Avanafil in Russia
Primary Objective: o To assess the change in percent of sexual attempts in which subjects are able to maintain an erection of sufficient duration to have successful intercourse between the run-in period and treatment period: The…
- Trial name
- CEDAR (NCT02503306)
- Testing
- AVANAFIL
- Where
- Russia
- Volunteers
- 189 people
- Sponsor
- Sanofi
BPH/LUTS/Sexual Functions
Multicenter Prospective Study on the Changes of Sexual Function Following Treatment With Alfuzosin (Xatral XL®) in Patients With Benign Prostate Hypertrophy
To collect under daily practice conditions, clinical data on the changes of sexual function when a new formulation of alfuzosin(Xatral XL® )is administered once daily in patients with lower urinary tract symptoms(LUTS) suggestive…
- Trial name
- NCT00542165
- Testing
- Alfuzosin
- Where
- South Korea
- Volunteers
- 166 people
- Sponsor
- Sanofi